On November 11, Piper Sandler analyst Harsh Kumar released an investor note on the AI market, noting that the CapEx trends at ...

Piper Sandler analyst Yasmeen Rahimi assigned a Buy rating to Praxis Precision Medicines (PRAX – Research Report) today and set a price target of $270.00. The company’s shares closed yesterday at ...

In a report released today, Christopher Raymond from Piper Sandler assigned a Buy rating to Taysha Gene Therapies (TSHA – Research Report), with a price target of $7.00. The company’s shares closed ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...

SolarEdge Technologies (NASDAQ:SEDG) +1.6% in Thursday's trading, a day after shares plunged 22% on concerns that the new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

Under Trump, bank deal approvals are likely to “speed up markedly and the process will be more clearly delineated,” one ...

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the ...

Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has demonstrated resilience and strategic growth in a dynamic financial landscape. The company's ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...